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ABSTRACT
Forebrain neurogenesis persists throughout life in the ro-
dent subventricular zone (SVZ) and hippocampal dentate
gyrus (DG). Several strategies have been employed to elim-
inate adult neurogenesis and thereby determine whether
depleting adult-born neurons disrupts specific brain func-
tions, but some approaches do not specifically target neural
progenitors. We have developed a transgenic mouse line to
reversibly ablate adult neural stem cells and suppress neu-
rogenesis. The nestin-tk mouse expresses herpes simplex
virus thymidine kinase (tk) under the control of the nestin
2nd intronic enhancer, which drives expression in neural
progenitors. Administration of ganciclovir (GCV) kills ac-
tively dividing cells expressing this transgene. We found that
peripheral GCV administration suppressed SVZ-olfactory
bulb and DG neurogenesis within 2 weeks but caused sys-
temic toxicity. Intracerebroventricular GCV infusion for 28
days nearly completely depleted proliferating cells and im-
mature neurons in both the SVZ and DG without systemic
toxicity. Reversibility of the effects after prolonged GCV
infusion was slow and partial. Neurogenesis did not recover
2 weeks after cessation of GCV administration, but showed
limited recovery 6 weeks after GCV that differed between
the SVZ and DG. Suppression of neurogenesis did not inhibit
antidepressant responsiveness of mice in the tail suspen-
sion test. These findings indicate that SVZ and DG neural
stem cells differ in their capacity for repopulation, and that
adult-born neurons are not required for antidepressant re-
sponses in a common behavioral test of antidepressant
efficacy. The nestin-tk mouse should be useful for studying
how reversible depletion of adult neurogenesis influences
neurophysiology, other behaviors, and neural progenitor dy-
namics. J. Comp. Neurol. 514:567–582, 2009.
© 2009 Wiley-Liss, Inc.
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Forebrain neurogenesis persists into adulthood in the mam-
malian subventricular zone (SVZ) adjacent to the lateral ven-
tricle and the subgranular zone (SGZ) of the hippocampal
dentate gyrus (Altman and Das, 1965; Altman, 1969a,b; Cam-
eron et al., 1993; Luskin, 1993; Lois and Alvarez-Buylla, 1994;
Kuhn et al., 1996; Eriksson et al., 1998). Neural progenitors in
the SVZ give rise to neuroblasts, which migrate tangentially
along the rostral migratory stream (RMS) to the olfactory bulb
and differentiate into interneurons (Luskin, 1993, 1998; Lois
and Alvarez-Buylla, 1994). Neuroblasts generated in the SGZ
migrate radially a short distance into the dentate granule cell
(DGC) layer and differentiate into granule cells (Cameron et al.,
1993; Kuhn et al., 1996).
Although evidence indicates that adult-generated olfactory
bulb and hippocampal neurons functionally incorporate into
existing neural circuits (Lledo and Lagier, 2006; Gheusi and
Lledo, 2007; Ge et al., 2008), the biological role of adult-born
neurons in the healthy and diseased brain remains unclear. In
the SVZ-olfactory bulb pathway, odor enrichment increases
the survival and excitability of adult-generated olfactory bulb
neurons and enhances olfactory memory performance (Roch-
efort et al., 2002; Rochefort and Lledo, 2005; Magavi et al.,
2005; Mandairon et al., 2006a; Alonso et al., 2006), but odor
deprivation has the opposite effect (Corotto et al., 1994; Man-
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dairon et al., 2003, 2006b; Enwere et al., 2004). Similarly,
environmental enrichment and exercise increase DGC neuro-
genesis (van Praag et al., 1999; Kempermann et al., 2002;
Brown et al., 2003), whereas aging and stress reduce the
addition of new cells (Gould et al., 1991, 1997; Kuhn et al.,
1996). Many different brain insults increase SVZ and DGC
neurogenesis in the adult (reviewed in Lichtenwalner and Par-
ent, 2006), underscoring the possibility that persistent neuro-
genesis may be useful for restorative therapy after brain injury.
Neurogenesis in the adult may also play a role in the patho-
physiology and treatment of mood disorders, such as anxiety
and depression (for review, see Elder et al., 2006; Schmidt and
Duman, 2007). Some animal models of depression have re-
duced proliferation of neuronal precursors (Chen et al., 2006;
Jaako-Movits et al., 2006; Lau et al., 2007; Surget et al., 2008)
and conversely, chronic antidepressant treatment may en-
hance cell proliferation and adult neurogenesis (Santarelli et
al., 2003; Perera et al., 2007; Surget et al., 2008). Although
studies of the biology of adult neurogenesis support a role for
adult-born neurons in olfactory bulb and hippocampal func-
tion, the implications are limited by their correlative nature.
To explore whether adult-born neurons are necessary for
aspects of brain function, several strategies have been em-
ployed for suppressing neurogenesis (Doetsch et al., 1999;
Gheusi et al., 2000; Mizumatsu et al., 2003; Morshead et al.,
2003; Koizumi et al., 2006; Zhang et al., 2008). Results of these
studies suggest that adult neurogenesis is necessary for
some, but not all, processes correlated to the birth and sur-
vival of adult-born neurons (Shors et al., 2001; Snyder et al.,
2001; Santarelli et al., 2003; Saxe et al., 2006). Indeed, manip-
ulation of adult neurogenesis has shown that addition of cells
to the adult brain is not necessary for the performance of
some behaviors linked to neurogenesis (Schellinck et al.,
2004; Meshi et al., 2006). Treatment with antimitotic drugs
(Doetsch et al., 1999; Shors et al., 2001) or brain irradiation
(Snyder et al., 2001; Mizumatsu et al., 2003) are potent meth-
ods for the reduction of neurogenesis. These approaches are
not specific for adult-born neurons, however, as they target all
dividing cells and thus may alter essential elements of the
neurovascular microenvironment and also induce inflamma-
tory responses. Studies using traditional knockout of genes
essential for neurogenesis also have proved useful, but their
interpretations may be limited by widespread abnormalities of
brain structure or compensatory effects elicited during devel-
opment (Gheusi et al., 2000; Koizumi et al., 2006).
The herpes simplex virus thymidine kinase (HSV-tk) gene
has been used successfully as a suicide gene that is toxic to
actively proliferating cells (Cheng et al., 1983; Heyman et al.,
1989; Bush et al., 1999). Using neural progenitor-specific gene
regulatory elements to drive expression of HSV-tk allows spe-
cific, temporally controlled ablation of adult neurogenesis. In
the presence of the antiviral drug ganciclovir (GCV), HSV-tk
produces toxic metabolites that disrupt DNA synthesis and
result in the death of dividing cells. Transgenic mice express-
ing HSV-tk from the glial fibrillary acidic protein (GFAP) pro-
moter have been used to explore both the identity of neural
progenitors in the brain (Morshead et al., 2003; Garcia et al.,
2004) and the role of adult neurogenesis in memory and re-
sponse to antidepressant drugs (Santarelli et al., 2003; Meshi
et al., 2006; Saxe et al., 2006,2007). However, the GFAP-tk
mouse mounts an altered response to brain injury (Bush et al.,
1999), and expression of GFAP outside the central nervous
system results in systemic toxicity following GCV administra-
tion (Bush et al., 1998).
Bearing in mind the goal of ablating adult neurogenesis
without altering the brain’s response to injury and disease, or
producing systemic toxicity that might affect behavioral per-
formance, we have generated a transgenic mouse expressing
HSV-tk from the 2nd intronic enhancer of the intermediate
filament gene nestin. Nestin is expressed by neural progenitor
cells in both the SVZ and SGZ (Yamaguchi et al., 2000; Maslov
et al., 2004; Ernst and Christie, 2005). The second intronic
enhancer element is sufficient to direct gene expression dur-
ing constitutive neurogenesis, but not during the response to
brain injury (Johansson et al., 2002). Thus, the nestin-tk mouse
may be particularly useful for studying the role of adult neu-
rogenesis in physiology, behavior, and regeneration after
brain injury. Here we characterize the loss of cellular prolifer-
ation and depletion of immature, adult-born neurons in the
nestin-tk mouse forebrain after systemic or intracerebroven-
tricular (ICV) administration of GCV. Administration of GCV by
the ICV route results in sustained, but partially reversible,
ablation of adult-born neurons in healthy, adult mice. Sup-
pression of neurogenesis in this model, moreover, does not
inhibit imipramine responsiveness of mice in the tail suspen-
sion test, suggesting that adult-born neurons are not required
for antidepressant-like effects in this behavioral paradigm.
MATERIALS AND METHODS
Animals
The tk gene from HSV type 1, with the DNA sequence of the
viral gene modified by humanizing the usage codon and elim-
inating all the CpGs (pMod-TK, Invitrogen, Carlsbad, CA), was
fused downstream of a minimal TK promoter element followed
by a 1.8-kb fragment of the 2nd intronic nestin enhancer (Fig.
1A) (Yaworsky and Kappen, 1999). The insert was purified for
pronuclear injection by the Transgenic Core at the University
of Michigan Diabetes Research and Training Center, and 13
founders from two separate injections were generated on an
FVB background. The mice appeared healthy with normal
growth and reproduction. Mice were genotyped by polymer-
ase chain reaction (PCR), and nestin-tk mice and wild-type
littermate controls were 8–12 weeks of age at the onset of
treatment. All procedures involving animals were approved by
the University Committee on the Use and Care of Animals of
the University of Michigan.
Neurosphere cultures
Neurosphere (NS) cultures were prepared as previously de-
scribed (Wang et al., 2005). Briefly, postnatal day 40 (P40)
nestin-tk mice and wild-type FVB littermates were anesthe-
tized with CO2, the brains were removed and cut into 2-mm-
thick coronal blocks, and the lateral SVZ was dissected,
minced, and dissociated with trypsin. Approximately 3–8 
104 SVZ cells per 60-mm dish were cultured in Dulbecco’s
modified Eagle’s medium (DMEM)/F12 (1:1, Gibco, Gaithers-
burg, MD) containing 20 ng/ml epidermal growth factor
(Sigma, St. Louis, MO) and 10 ng/ml basic fibroblast growth
factor (Sigma). Primary NS were cultured for 6 days in vitro,
mechanically dissociated and passaged to form secondary
NS at 6  103 cells per well in 12-well plates. To examine the
effect of GCV on NS formation, NS were cultured: 1) in GCV-
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free medium as a control; 2) in medium containing 9 M GCV
for 24 hours and then in GCV-free medium for 4 days; or 3) in
medium containing 9 M GCV for 5 days. At the end of the
5-day culture period, NS were measured and counted based
on their diameters: small (<0.1 mm), medium (0.1–0.8 mm),
and large (>0.8 mm).
In vivo GCV administration
For pilot studies, 100 mg/kg GCV (Cytovene, Roche, India-
napolis, IN) or 100 mg/kg elaidic acid esterified GCV (eGCV
CP-4018, Clavis Pharma, Oslo, Norway; Balzarini et al., 1998)
was administered daily via intraperitoneal (i.p.) injection. To
improve penetration of the blood-brain barrier, eGCV was
prepared in a liposomal solution according to the manufac-
turer’s instructions. Briefly, a solution of eGCV (25 mg/ml) and
phosphotidyl choline (100 mg/ml; Sigma) in ethanol was rap-
idly injected into water. The resulting suspension was then
frozen (80°C) and lyophilized. The dried product was resus-
pended in a solution of glycerol and water (22.4 mg/ml) and
briefly sonicated. In some experiments, osmotic minipump
(Alzet, Cupertino, CA, model 2004) subcutaneous infusion was
used as described previously (Garcia et al., 2004).
Due to the adverse systemic effects of i.p. or subcutaneous
GCV and eGCV administration, for all subsequent experiments
we administered GCV via ICV infusion at a rate of 0.25 l/hr by
using an osmotic minipump. Minipumps (Alzet, model 2004)
were filled with 20 mM GCV or normal saline and primed for 36
hours at 37°C. For implantation of the pump and cannula,
mice were anesthetized with 130 mg/kg ketamine and 20
mg/kg xylazine and fixed to a stereotaxic frame after loss of
the paw withdrawal reflex. The osmotic pump was implanted
subcutaneously over the scapulae, and fitted to an intraven-
tricular cannula (Brain Infusion Kit 3, Alzet) implanted 0.21 mm
anterior, 0.85 mm lateral, and 3.0 mm deep to Bregma. Fol-
lowing surgery, all mice were housed individually for the re-
mainder of the experiment.
Bromodeoxyuridine labeling and tissue processing
Pulse bromodeoxyuridine (BrdU) labeling was used to iden-
tify mitotically active cells. BrdU (100 mg/kg) dissolved in
phosphate-buffered saline (PBS; pH 7.4) was administered
once by i.p. injection, and 2 hours later animals were killed by
anesthetic overdose. Brains were perfusion-fixed with 0.9%
NaCl, followed by 4% paraformaldehyde (PFA) in phosphate
Figure 1.
Ganciclovir (GCV) administration suppresses formation of neurospheres (NS) derived from P40 nestin-tk mouse SVZ. A: This schematic of the
nestin-tk construct shows that expression of the HSV-tk gene is under control of a nestin 2nd intronic enhancer element and minimal tk
promoter. Administration of GCV to mice carrying this transgene results in death of dividing cells expressing HSV-tk. B: Culture of NS in
GCV-containing media for 24 hours or 5 days results in decreased NS formation from nestin-tk (tk) mice relative to GCV-treated wild-type
controls (wt; P < 0.001) or tk NS cultures in basal media (P < 0.001) after 5 days in vitro. Black bars indicate number of large (L), medium-sized
(M), and small (S) NS derived from wt mice, whereas gray bars denote those derived from tk mice. C–H: Representative phase contrast images
of cultured NS after 5 day in vitro. NS from tk mice cultured in GCV-containing media are markedly reduced (G,H) relative to those cultured
in control media (F) or to cultures from wt controls grown in the presence or absence of GCV (C–E). Scale bar  100 m in C (applies to C–H).
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buffer. In another set of experiments, BrdU was given once
daily on days 10–12 after the start of the ICV infusion of GCV,
and animals were killed at the end of the 28-day infusion.
Brains were removed and postfixed overnight in 4% PFA,
cryoprotected with 30% sucrose, embedded in freezing me-
dium, frozen in dry ice and 2-methyl butane, and sectioned
coronally at 50-m thickness.
Immunohistochemistry
For immunofluorescence labeling, sections were rinsed in
Tris-buffered saline (TBS; pH 7.4) and incubated in blocking
buffer for 1 hour prior to incubation with primary antibody.
After three TBS washes, sections were incubated with Alexa
Fluor 594- or 488-conjugated goat anti-mouse, -rat, or -rabbit
IgG secondary antibody (1:400; Molecular Probes, Eugene,
OR) at room temperature for 2 hours, washed three times with
TBS, mounted on slides, and coverslipped with antifade me-
dium (Pro-Long; Molecular Probes). For BrdU immunofluores-
cence, sections were incubated with 2 N HCl at 37°C for 30
minutes to denature the DNA and then neutralized with 0.1 M
sodium borate (pH 8.5) for 10 minutes. After TBS washes,
sections were incubated with rat anti-BrdU (1:200; Accurate
Chemical, Westbury, New York) at 4°C overnight and then
processed as described above.
For diaminobenzidine (DAB) staining, sections were pro-
cessed as follows: rinses with Tris buffer, deactivation of
endogenous peroxidases with 1% H2O2, rinses with Tris
buffer containing Triton X-100/bovine serum albumin (Tris-B),
blocking with 10% normal goat serum in Tris-B for 1 hour, and
then incubation with primary antibody at 4°C overnight (see
below). After Tris buffer washes, sections were incubated with
biotinylated horse anti-goat IgG (1:200; Jackson ImmunoRe-
search, West Grove, PA) and then avidin-biotin peroxidase
(ABC) complex (Vector, Burlingame, CA). For color reaction,
sections were incubated with stable DAB (Invitrogen), rinsed
three times, mounted on slides, and coverslipped with Per-
mount medium. For BrdU immunohistochemistry, sections
were incubated with 2 N HCl at 37°C for 30 minutes to dena-
ture the DNA, and then neutralized with 0.1 M sodium borate
(pH 8.5) for 10 minutes. After Tris washes, sections underwent
peroxidase deactivation, rinsing, and blocking as above and
incubation with mouse anti-BrdU (1:1,000, Roche) overnight at
room temperature. After Tris washes, sections were incubated
with biotinylated horse anti-mouse IgG (1:200; Jackson Immu-
noResearch) and processed with ABC complex and DAB as
above. Images were captured with a Leica DSM-IRB epifluo-
rescence microscope and Spot-RT digital camera or, for dou-
ble labeling, as a z-series of thin optical sections with a Zeiss
LSM-510 confocal microscope. Digital images were imported
into Adobe Photoshop v.6.0 (Adobe Systems, Mountain View,
CA). Contrast and brightness were adjusted slightly to keep
background intensity levels comparable among animals.
Antibody characterization
The monoclonal mouse anti-BrdU antibody (Roche,
1170376) was prepared against a BrdU-bovine serum albumin
conjugate; it cross-reacts with iodouridine at 10% of the in-
tensity of BrdU, but not fluorodeoxy-uridine, nor with any
endogenous cellular components such as thymidine or uridine
(manufacturer’s information). Antibody was used at 1:1,000
titer, and staining was absent in tissue from mice not injected
with BrdU. The monoclonal rat anti-Brdu antibody (Accurate
Chemical, OBT0030CX) was prepared against iodouridine
conjugated to bovine serum albumin; it does not cross-react
with thymidine (manufacturer’s information; Vanderlaan and
Thomas, 1985). Antibody was used at 1:200 titer, and staining
was absent in tissue from mice not injected with BrdU.
The polyclonal goat anti-doublecortin (DCx) antibody (Santa
Cruz Biotechnology, Santa Cruz, CA; sc-8066, C-18 clone)
was prepared against the C-terminal of a synthetic DCx pep-
tide corresponding to amino acids 385–402 at the C-terminus
of human DCx (Swiss-Prot #O43911). The anti-DCx sc-8066
antiserum recognizes a 45-kDa band by Western blot of hu-
man DCx-transfected 3T3-L1 whole cell lysate, does not react
to lysate of untransfected cell lines, and is specific to DCx of
mouse, rat, and human origin by Western blotting, immuno-
precipitation, and immunohistochemistry; it does not cross-
react with a related protein, KIAA0369 (manufacturer’s infor-
mation). The pattern of C-18 staining observed was consistent
with that of previous studies that have examined birth-dating
of DCx-immunoreactive neurons (Brown et al., 2003). Anti-
body was used at 1:2,000 titer.
The monoclonal mouse anti-GFAP antibody (Sigma; G3893,
G-A-5 close) was prepared against GFAP purified from pig
spinal cord; it recognizes GFAP-containing astrocytes and a
50-kDa protein on Western blots (manufacturer’s information;
Latov et al., 1979). Antibody was used at 1:500 titer.
The polyclonal rabbit anti-glucose transporter 1 (GLUT1)
antibody (Chemicon, Temecula, CA; AB1340) was prepared
against a synthetic peptide corresponding to amino acids at
the C-terminus (C-ELFHPLGADSQV) of rat GLUT-1 (Swiss-
Prot #P11166) coupled to keyhole limpet hemocyanin (KLH). It
recognizes both the 55- and 45-kDa forms of GLUT1 on West-
ern blot and does not react to colorectal cancer controls; it
recognizes GLUT1 in human, mouse, and rat tissue (manufac-
turer’s information; Smoak and Branch, 2000). Antibody was
used at 1:800 titer.
The polyclonal rabbit anti-Ki67 antibody (Vector; VP-K451)
was prepared against an isolated 20-mer peptide (NH2-
AGGDEKDIKAFMGTPVQKLD-COOH) corresponding to a
62-bp cDNA containing the Ki67 motif (Key et al., 1993a,b).
This rabbit antiserum was shown to detect 345- and 395-kDa
bands on Western blot of lysed IM-9 cells, the same bands
detected by the monoclonal Ki-67 antibody used to define the
motif. The antibody was used at 1:500 titer and resulted in
nuclear staining in proliferative brain regions consistent with
that observed by other authors (Maslov et al., 2004).
The polyclonal goat anti-mini-chromosome maintenance
protein 2 (MCM2) antibody (Santa Cruz Biotechnology; sc-
9839, N-19 clone) was prepared against a synthetic peptide
corresponding to amino acids 1–30 at the N-terminus of hu-
man MCM2 (Swiss-Prot #P49736, manufacturer’s informa-
tion). The anti-MCM2 sc-9839 antiserum recognizes a 127-
kDa band in nuclear extract of HeLa cells and is specific to
MCM2 of rat, mouse, and human origin (manufacturer’s infor-
mation). The pattern of MCM-2 staining observed was consis-
tent with that of previous studies examining double labeling of
MCM-2 and BrdU (Maslov et al., 2004). Antibody was used at
1:200 titer.
The monoclonal mouse anti-NeuN antibody (Chemicon;
MAB377, clone A60) was prepared against purified nuclei from
mouse brain cells. The anti-NeuN antibody recognizes two to
three bands in the 46–48-kDa range and is specific to nuclei
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only of postmitotic neurons (manufacturer’s information;
Mullen et al., 1992). Antibody was used at 1:1,000 titer.
The monoclonal mouse anti-nestin antibody (Dr. Susan
Hockfield, Developmental Studies Hybridoma Bank, Univer-
sity of Iowa, Ames, IA; Rat-401) was prepared against homog-
enized E15 rat spinal cords. The anti-nestin antibody recog-
nizes a single 200-kDa band on Western blot; it stains
neuroepithelial cells including neuronal progenitors (Hockfield
and McKay, 1985). Antibody was used at 1:10 titer.
The monoclonocal rat anti-ED-1 antibody (Serotec, Bices-
ter, UK; MCA1957) is raised against concavalin A acceptor
protein from the P815 cell line (manufacturer’s information).
This antibody recognizes bands of 87–115 kDA corresponding
to differentially glycosylated forms of ED-1 (da Silva and Gor-
don, 1999). In this study, the antibody was used at 1:200 titer.
Staining revealed numerous small stellate cells, and staining
of positive control tissue from known inflammatory states
showed increased numbers of reactive cells.
Cell counting
Stereological estimates of cell number were performed with
a computer-aided microscopy system (Visiopharm, Horsholm,
Denmark) coupled to an Olympus BX51 microscope. Due to
the low total number of labeled cells in each section, the entire
region of interest in every 12th section through the DG con-
tralateral to the site of ICV cannula implantation was examined
at high power by using a 60, NA 1.35 oil immersion objective.
In sections labeled for DCx, the region of interest comprised
the entire granule cell layer of any section with a discernible
border between the DGC layer and dentate hilus. In sections
labeled for BrdU, the region of interest extended from the
inner half of the DGC layer and penetrated two granule cell
body widths into the dentate hilus. Blinded cell counts were
then estimated by using an optical fractionator probe (West et
al., 1991). The coefficent of variation in the set of sections
from each mouse was calculated (Gundersen et al., 1999;
Bermejo et al., 2003) and found to be less than 5%.
Tail suspension test
Mice were implanted with an ICV cannula and received a
continuous infusion of GCV for 28 days as previously de-
scribed. Fourteen days after implantation, mice were injected
(i.p.) once daily for 28 days with a single dose of imipramine (3,
10, or 30 mg/kg) or saline. Thirty minutes after the last imip-
ramine dose, each mouse was evaluated in the tail suspension
test. For this behavioral assay, tape was attached to the
bottom half of each mouse’s tail, and then it was secured to a
metal pole suspended approximately 8 inches from a table
surface. The mouse remained suspended and was videotaped
for 6 minutes. The videotape was later scored for duration of
immobility by one or two observers blind to the drug treatment
and genotype; interscorer reliability was greater than 90%.
Immobility was defined as continuous periods of stillness,
with an occasional small movement or isolated twitch al-
lowed. Following the tail suspension test, brain tissue from
each mouse was perfused and fixed as previously described.
Imipramine was dissolved and diluted in saline, and all injec-
tions were administered in a volume of 1 ml/100 g of body
weight.
Statistics
Comparisons among cell or NS counts in multiple treatment
groups were performed by using one-way ANOVA, with post
hoc t-tests and groupwise contrasts adjusted for multiple
comparisons by Tukey’s criterion. When appropriate, pairwise
comparisons were made by using Student’s t-test. All tests
were two-tailed. Analyses of cell counts were performed by
using SPSS 15 software (SPSS, Chicago, IL). Behavioral data
were analyzed by one- or two-way ANOVA with Dunnett’s post
hoc test (Graphpad Prism [La Jolla, CA] software). If no inter-
action was observed, post hoc analyses were conducted on
significant main effects. Data are presented as the mean plus
1 SEM, and P < 0.05 was accepted as statistically significant.
RESULTS
GCV suppresses nestin-tk cell proliferation in
vitro
We first sought to determine whether the proliferation of
postnatal neural stem cells could be suppressed in vitro by
the administration of GCV in the presence of the nestin-tk
transgene (Morshead et al., 2003). Neural stem cells from the
postnatal rodent forebrain expand in vitro when cultured as
floating NS (Gritti et al., 1996; Reynolds and Weiss, 1992; Gritti
et al., 1996; Tropepe et al., 1999; Seaberg and van der Kooy,
2002). We therefore derived NS cultures from the SVZ of P40
nestin-tk mice and wild-type littermates, cultured them for 5
days after first passage in the presence or absence of GCV,
and analyzed the NS based on their numbers and sizes (small,
<0.1 mm; medium, 0.1–0.8 mm; and large, >0.8 mm).
Cultures derived from wild-type mice produced similar
numbers of NS regardless of whether they were grown in
GCV-free media or in media containing 9 M GCV for 24 hours
or for the entire 5-day culture period (Fig. 1B–E). Cultures from
nestin-tk mice, however, produced significantly fewer small
and medium-sized secondary NS when exposed to GCV for
either 24 hours or 5 days than when grown in basal media, or
when compared with wild-type derived cultures grown with
GCV (F(17,54)  355.7, P < 0.001; Fig. 1B–H). The number of
large nestin-tk NS was also reduced in the presence of GCV
compared with wild-type cultures treated with GCV and
nestin-tk cultures in basal media, but the difference was not
significant. In addition, nestin-tk cultures in basal media
produced slightly, but significantly, fewer NS than wild-type
derived cultures under the same conditions (P < 0.001; Fig.
1B,C,F).
These findings indicate that in vitro treatment with GCV in
the presence of the nestin-tk transgene suppresses NS for-
mation from postnatal SVZ-derived neural progenitors. This
effect was observed after 5 days of continuous GCV exposure
or after 24 hours of GCV exposure followed by 4 days in basal
media, suggesting that GCV administration results in a rapid,
prolonged ablation of a large portion of the stem cell popula-
tion in vitro. As expected, GCV did not influence the prolifer-
ation of SVZ stem cells derived from wild-type mice. We did
note, however, that NS formation was slightly diminished in
cultures derived from nestin-tk mice versus wild-type even in
the absence of GCV (Fig. 1B, left side), raising the possibility
that either the transgene product or site of insertion has a
deleterious effect on stem cell proliferation.
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In the absence of GCV treatment, the nestin-tk
transgene does not impair basal cell proliferation
and adult neurogenesis in vivo
Before conducting experiments evaluating the effect of
GCV on adult neurogenesis in vivo, we examined whether the
presence of the nestin-tk transgene alone altered forebrain
SVZ and dentate SGZ cytogenesis. Three-month-old mice
received a single BrdU injection (100 mg/kg, i.p.), and the
pattern of BrdU immunoreactivity was examined 2 hours later.
The forebrain SVZ of both untreated wild-type and untreated
nestin-tk mice contained a similar pattern of large numbers
of BrdU-immunoreactive nuclei (Fig. 2A,B). The dentate SGZ
contained clusters of BrdU-labeled cells (Fig. 2E,F), and no
difference was found in the number of BrdU-immunoreactive
cells in the SGZ of nestin-tk mice and wild-type littermates
(P > 0.5, Fig. 2G; n  6/group). Although pulse BrdU labeling
reveals the number of S-phase cells during a brief time, we
sought a more integrated view of neurogenesis by examining
immunoreactivity for DCx, a microtubule binding protein ex-
pressed by immature neurons for several weeks after birth
(Brown et al., 2003; Couillard-Despres et al., 2005). Both wild-
type and nestin-tk mice displayed abundant DCx immuno-
reactivity in the SVZ and in the DGC layer (Fig. 2C,D,H,I). There
was no significant difference in the number of DCx cells in
the DG of wild-type and nestin-tk mice (Fig. 2J; P > 0.5, n 
6/group). Thus, despite the small disparity in proliferative po-
tential among nestin-tk and wild-type NS observed in vitro,
the presence of the nestin-tk transgene does not reduce the
rates of cell division or neurogenesis in vivo in the main
neurogenic regions of the adult brain. Additional studies using
other nestin-tk mouse lines would be helpful to establish the
reason for the differences we found in vitro.
Systemic GCV administration in adult nestin-tk
mice suppresses SVZ and SGZ cell proliferation
To determine whether GCV treatment would effectively re-
duce neurogenesis in nestin-tk mice in vivo, we first exam-
ined the effect of systemically administered GCV on cytogen-
esis in the SVZ and SGZ. Adult mice received a liposomal
solution of eGCV for 14 days (100 mg/kg/d, i.p.). On the day
after eGCV treatment ended, a single pulse of BrdU (100
mg/kg) was administered, and BrdU immunoreactivity was
examined 2 hours later. Although the SVZ and SGZ of wild-
type animals treated with eGCV showed robust BrdU labeling
commensurate with untreated controls (Fig. 2K,M), BrdU la-
beling was dramatically reduced in nestin-tk mice after
eGCV treatment (Fig. 2L,N). Similarly, nestin immunoreactivity
in the SVZ was virtually absent after eGCV administration in
nestin-tk mice (Fig. 2O,P). Comparable findings were seen
after GCV was administered subcutaneously (data not shown).
These results indicate the potential of systemic GCV admin-
istration in nestin-tk mice to achieve cytostasis in neuro-
genic regions, and indeed to deplete the population of nestin-
expressing progenitor cells.
Peripheral administration of either GCV or eGCV in a con-
centration and duration sufficient to suppress cell division in
the SVZ and SGZ, however, also resulted in significant sys-
temic toxicity. Nestin-tk mice lost up to 30% of their body
weight and suffered 100% mortality by 16 days after the
initiation of GCV or eGCV administration. The mortality that
accompanied GCV treatment may relate to ablation of nestin-
expressing pancreatic cells, as we found that the weight of the
pancreatic mass in nestin-tk mice was reduced by over 50%
after GCV treatment compared with GCV-treated wild-type
controls (data not shown). Despite multiple experiments vary-
ing GCV and eGCV concentrations, administration rate, and
peripheral administration route, including subcutaneous os-
motic minipump infusion (Garcia et al., 2004), we were unable
to achieve effective concentrations of GCV in the brain with-
out causing systemic toxicity.
ICV infusion of GCV ablates proliferation and
neurogenesis in the SVZ and SGZ
We sought to take advantage of the limited capacity of GCV
to cross the blood-brain barrier (Bodor and Buchwald, 1999)
and circumvent systemic effects by infusing GCV directly into
the lateral ventricle. Mice were implanted with an ICV cannula
and received a continuous infusion of 2 mM GCV or saline
vehicle for 28 days via osmotic minipump (n  7 tk  GCV,
5 tk  vehicle, 4 wild-type  vehicle). The 28-day infusion
duration was chosen to eliminate an extensive cohort of adult-
born neurons over the time that they would begin to integrate,
2–4 weeks (reviewed in Ming and Song, 2005), in preparation
for later behavioral studies. Utilizing this administration route,
we did not observe any differences in the overt behavior of
wild-type or nestin-tk mice, and there was no mortality fol-
lowing GCV administration. In addition, the weights of the
mice did not differ after GCV infusion (wild-type: mean 31.1 
1.6 g; nestin-tk: mean 29.9  1.2 g, P > 0.5, n  12/group).
Following 28 days of ICV infusion, we examined proliferation
and neurogenesis in the SVZ-olfactory bulb pathway and hip-
pocampal DG. The number of mitotically active cells in the
SVZ labeled by the cell-cycle protein Mcm2 (Maslov et al.,
2004) was greatly reduced in nestin-tk mice after GCV ad-
ministration (Fig. 3C) compared with vehicle-treated trans-
genic and GCV-treated wild-type controls (Fig. 3A,B). We ob-
served the same result by using Ki67 labeling as a marker of
cell proliferation (data not shown). This reduction in precursor
proliferation was further reflected in the complete loss of
DCx-immunoreactive neuroblasts in the SVZ (Fig. 3D–F) and
olfactory bulb (Fig. 3Gb–I) of nestin-tk mice following GCV
treatment.
The suppression of neurogenesis was also effective in the
DG. After 28 days of GCV treatment, the SGZ of nestin-tk
mice was nearly completely devoid of proliferating cells la-
beled by Mcm2 (Fig. 4A–C) or Ki67 (data not shown). The
Figure 2.
A–J: Immunolabeling for bromodeoxyuridine (BrdU) (A,B,E,F) and
doublecortin (DCx) (C,D,H,I) shows robust cell proliferation and pro-
duction of immature neurons in both the subventricular zone (SVZ;
A–D) and dentate gyrus (DG; E,F,H,I) of untreated, 3-month-old wild-
type (wt) and nestin-tk (tk) mice. No significant difference in ste-
reological estimates of the number of BrdU (G) or DCx (J) immunola-
beled cells in the DG was observed between untreated wt or tk mice.
K–P: Intraperitoneal injection of eGCV for 14 days dramatically re-
duces proliferation, as indicated by labeling for pulse-administered
BrdU, in the SVZ (L) and SGZ (N) of tk mice relative to wt controls
(K,M). BrdU was injected 2 hours prior to perfusion. The population of
nestin-positive cells in the SVZ is also depleted in tk mice (P) com-
pared with controls (O). LV, lateral ventricle; STM, striatum; cc, corpus
callosum; GCL, granule cell layer; H, hilus; ML, molecular layer. Scale
bar  200 M in A (applies to A–D), E (applies to E,F,H,I), K (applies to
K,L), and 100 m in M (applies to M,N) and O (applies to O,P).
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number of immature neurons in the DGC layer labeled by DCx
was also reduced by 95% (F(2,14)  6.88, P < 0.01) in nestin-
tk mice receiving GCV, whereas there was no difference in
the number of DCx-labeled cells among nestin-tk mice
treated with vehicle and GCV-treated wild-type mice (P >
0.05; Fig. 4D–G). To confirm the reduction in neurogenesis, we
administered BrdU during days 10–12 of the GCV infusion and
perfused animals at the end of the 28-day infusion. Analysis of
Figure 3.
ICV infusion of ganciclovir (GCV) for 28 days dramatically reduces both cell proliferation and the number of immature neurons in the
SVZ-olfactory bulb pathway of nestin-tk (tk) mice. A–C: Whereas the SVZ of both vehicle-treated tk (A) and GCV-treated wild-type (wt; B)
mice contains numerous mitotically active cells labeled by MCM2, little labeling is observed in the SVZ of tk mice treated with 28 days of GCV
(C). D–F: Immature neurons labeled by double cortin (DCx) are absent from the SVZ of tk mice treated with GCV (F) , but are not depleted in
vehicle (veh)-treated (D) or GCV-treated (E) controls. G–I: The ultimate destination of neurons generated in the SVZ, the olfactory bulb, also
demonstrates reduced DCx labeling of immature neurons in tk mice treated with GCV (I) relative to controls (G,H). LV, lateral ventricle; STM,
striatum; cc, corpus callosum; SEL, olfactory subependymal layer; GCL, granule cell layer; GLL, glomerular layer. Scale bar  100 m in A
(applies to A–C), D (applies to D–F), and G (applies to G–I).
Research in Systems Neuroscience The Journal of Comparative Neurology
574 B.H. SINGER ET AL.
double labeling for BrdU and the mature neuronal marker
NeuN by confocal microscopy showed that about 50% of
BrdU-labeled cells co-expressed NeuN in wild-type controls
treated with GCV, whereas no double labeling was found in
GCV-treated, nestin-tk animals (Fig. 4H,I; n  3 mice/group).
Furthermore, we did not observe any differences in GFAP and
Glut1 immunoreactivity in the DG among nestin-tk and wild-
type mice treated with GCV, suggesting that the loss of mi-
totically active precursors does not elicit frank gliosis or vas-
cular changes in the hippocampus (data not shown; Latov et
al., 1979; Smoak and Branch, 2000). Further supporting a lack
of inflammatory response in nestin-tk mice treated with GCV,
we found no increase in activated microglia by ED-1 immu-
nostaining except along the cannula track, and the degree
was similar between treatment and control groups.
These results demonstrate that ICV administration of GCV
for 28 days leads to a dramatic reduction in cellular prolifer-
ation in both neurogenic regions of the adult mouse brain.
Moreover, this loss of proliferation leads to a nearly complete
depletion of DCx-immunoreactive cells in both the olfactory
bulb and DG. Because immature neurons express DCx for
several weeks following their birth, their absence suggests
that neurogenesis is suppressed rapidly and that the suppres-
sion is maintained for the duration of GCV administration
(Brown et al., 2003). Depletion of adult-born neurons was
further suggested by the absence of double labeling for BrdU
and the mature neuronal marker NeuN.
Proliferation and neurogenesis recover slowly
after cessation of GCV administration
The nearly complete ablation of neurogenesis following 28
days of GCV administration suggests that the pool of nestin-
expressing progenitor cells may be gradually depleted as they
enter the cell cycle. To study the capacity of the remaining
SVZ and SGZ progenitors to restore newborn neurons to the
olfactory bulb and DG after a period of suppression, we ter-
Figure 4.
ICV infusion of ganciclovir (GCV) for 28 days dramatically reduces both cell proliferation and the number of immature neurons in the DG of
nestin-tk (tk) mice. A–C: Whereas the SGZ of both vehicle-treated nestin-tk (tk) and GCV-treated wild-type (wt) mice contains numerous
mitotically active cells expressing Mcm2 (A, B), few cells label for this cell cycle marker in the SGZ of tk mice treated with 28 days of GCV (C).
D–F: Immature neurons immunolabeled for double cortin (DCx) are absent from the DG of tk mice treated with GCV (F), but are not depleted
in vehicle-treated tk (D) or GCV-treated wt (E) controls. G: Quantitative analysis shows that DCx-immunoreactive cell numbers are 95% lower
in GCV-treated tk mice than in either control group (P < 0.01). H,I: Representative confocal images of sections double-labeled for BrdU
(magenta) and NeuN (green) show both double-labeled (arrow) and single-labeled (arrowhead) cells in the granule cell layer (GCL) of a
GCV-treated wt control (H), but only a cell single-labeled for BrdU in a tk animal after 28 days of GCV treatment (arrowhead in I). Nonmerged
images of the double-labeled cell (arrow) are shown as insets in H. BrdU was given 16–18 days earlier (days 10–12 of GCV infusion). D, dentate
gyrus; H and h, hilus; GCL and gcl, granule cell layer; ML, molecular layer. Scale bar  50 m in A (applies to A–C), D (applies to D–F), and H
(applies to H,I).
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minated GCV administration after 28 days and examined mice
following a 2-week or 6-week recovery period. Following 2
weeks of recovery after GCV treatment, no DCx-labeled neu-
roblasts or interneurons were observed in either the SVZ or
OB, respectively, in nestin-tk mice (Fig. 5A–D). Similarly, the
DG was devoid of DCx-immunoreactive cells in nestin-tk
mice compared with wild-type animals (Fig. 5E–G; P < 0.001;
n  3/group).
The lack of DCx-labeled cells in either the SVZ or DG after
2 weeks of recovery could reflect complete ablation of the
neural progenitor population, or could result from the relative
quiescence of progenitors that survive the death of dividing
cells during GCV administration. We therefore examined the
SVZ-olfactory bulb pathway and DG 6 weeks after the cessa-
tion of GCV to allow for additional expansion and differentia-
tion of the progenitor population. In the SVZ, some cells ex-
pressing Mcm2 (Fig. 6A,B) and Ki67 (data not shown)
appeared in both nestin-tk and wild-type control mice fol-
lowing 6 weeks of recovery from GCV treatment. In addition,
DCx-immunoreactive neuroblasts were present in the SVZ
and olfactory bulb in nestin-tk mice, albeit at reduced num-
bers compared with wild-type controls (Fig. 6C–F).
Proliferating cells and immature neurons also began to re-
populate the DG after 6 weeks of recovery (Fig. 7). However,
unlike the recovery of neurogenesis in the SVZ, which was
present bilaterally, nascent recovery of neurogenesis was only
evident unilaterally in the SGZ. Although Mcm2- and Ki67-
labeled cells were present bilaterally in wild-type controls
after 28 days of ICV GCV treatment and 6 weeks of recovery
(Fig. 7A; Ki67, data not shown), they were only evident in
nestin-tk mice in the SGZ contralateral to the side of GCV
infusion (Fig. 7B; Ki67, data not shown). Similarly, no DCx-
labeled cells were present ipsilateral to the infused lateral
ventricle, whereas sparse labeling was observed contralater-
ally (Fig. 7D,E). Quantification of DCx-immunoreactive cells
revealed a significant decrease ipsilaterally (Fig. 7E; F(2,10) 
8.34, P < 0.01; n  7/group) and a trend toward persistent
reduction contralaterally (P < 0.125) compared with GCV-
treated, wild-type controls. Nestin and GFAP immunoreactiv-
ity persisted in radial glia-like cells in the DG of tk mice after
the 28-day GCV infusion (data not shown), suggesting that
type 1 stem-like cells were not entirely eliminated. Thus, the
repopulation dynamics after 28 days of GCV administration
indicate that some progenitor cells survive throughout the
period of GCV infusion and are able to reconstitute neurogen-
esis, although neurogenesis recurs bilaterally in the SVZ but
only in the DG contralateral to the GCV infusion.
Ablation of proliferation and neurogenesis does
not alter the antidepressant-like effects of
imipramine in vivo
Reductions in forebrain neurogenesis were evaluated in an
animal model used to identify antidepressant-like activity, the
mouse tail suspension test. In nonimplanted, wild-type FVB
mice, chronic imipramine administration dose-dependently
decreased immobility in the tail suspension test (F(3,22) 
9.67, P  0.0004; Fig. 8A). Significant decreases were ob-
served at 10-mg/kg (P < 0.05) and 30-mg/kg (P < 0.001)
doses compared with saline treatment. Chronic imipramine
administration also decreased immobility in single-housed,
GCV-treated wild-type littermate and nestin-tk mice (main
effect for imipramine: F(3,62)  13.41, P < 0.0001; Fig 8B);
however, the nestin-tk transgene did not significantly alter the
effects of imipramine (interaction: F(3,62)  0.15, P  0.93;
main effect for nestin-tk transgene: F(1,62)  0.014, P  0.91).
Significant decreases in immobility were observed at 10
mg/kg (P < 0.05) and 30 mg/kg (P < 0.001) compared with
saline independent of the transgene. As expected, GCV treat-
ment led to a nearly complete cessation of neurogenesis only
in transgenic mice (Fig. 8C,D). GCV treatment did not mark-
edly attenuate DCx immunoreactivity in two of seven nestin-
tk mice in the 30-mg/kg imipramine dose group, but exclu-
Figure 5.
Two weeks after discontinuation of a 28-day ganciclovir (GCV) infu-
sion, immature neurons remain absent from the SVZ, olfactory bulb,
and DG. A–D: The SVZ (B) and olfactory bulb (D) of a nestin-tk (tk)
mouse does not contain any doublecortin (DCx)-immunoreactive neu-
roblasts after a 2-week recovery period, whereas a GCV-treated con-
trol (wt) shows many labeled cells (A,C). E,F: No immature neurons are
observed in the DG of a tk mouse immunolabeled for DCx (F) after a
2-week recovery period, compared with the robust labeling evident in
the GCV-treated wt (E). G: Stereological cell counts of DCx-
immunoreactive cells show failure of the DG to reconstitute neurogen-
esis following 2 weeks of recovery from a 28-day GCV infusion in tk
mice versus wt controls (P < 0.001). DG, dentate gyrus; LV, lateral
ventricle; STM, striatum; CC, corpus callosum; SEZ, GCL, olfactory or
dentate granule cell layer; SEL, olfactory subependymal layer; GLL,
glomerular layer; H, dentate hilus. Scale bar  100 m in A (applies to
A,B), C (applies to C,D), and E (applies to E,F).
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sion of these two mice did not change results of the analysis
(interaction: F(3,60)  0.03, P  0.99; main effect for nestin-tk
transgene: F(1,60)  0.02, P  0.89l; main effect for imipra-
mine: F(3,60)  14.22, P < 0.000l). Similar behavioral effects
were observed between nonimplanted FVB mice and GCV-
treated wild-type and nestin-tk mice, demonstrating that
Figure 6.
Six weeks after discontinuation of a 28-day ganciclovir (GCV) infusion, both cell proliferation and neurogenesis recover in the SVZ. A,B: After
6 weeks of recovery, the SVZ of nestin-tk (tk) mice treated with GCV for 28 days contains proliferating cells labeled by Mcm2 (B).
Mcm2-labeled cells are found both ipsilateral (I, lower left) and contralateral (C, lower left) to the implantation site of the ICV cannula, although
they are less numerous than observed in wild type (wt) controls after the same GCV treatment and recovery period (A). C,D: Neurogenesis also
returns bilaterally in the SVZ after 6 weeks of recovery. Immature neurons immunolabeled for doublecortin (DCx) appear in the SVZ of both tk
mice (D) and wt controls (C), although they are less numerous in the tk animal (D). E,F: Recovery of neurogenesis is sufficiently established after
6 weeks that immature neurons are evident in the olfactory bulb of a tk mouse (F); however, the numbers have not returned to control levels
(E). LV, lateral ventricle; STM, striatum; CC, corpus callosum; SEL, olfactory subependymal layer; GCL, granule cell layer; GLL, glomerular layer.
Scale bar  100 m in A (applies to A–D) and E (applies to E,F).
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surgical implantation and ICV infusion of GCV did not have
any significant behavioral consequences for baseline immo-
bility behavior or on the effects of imipramine. These data
therefore indicate that adult neurogenesis is not required for
antidepressant-like responses of mice in the tail suspension
model of antidepressant efficacy.
DISCUSSION
Our results indicate that administration of GCV to mice ex-
pressing the nestin-tk transgene effectively ablates adult neuro-
genesis in both the SVZ/OB and SGZ/DG pathways. Infusion of
GCV into the lateral ventricle for 28 days led to suppression of
cell proliferation in both the SVZ and SGZ, and depletion of
immature neuronal populations in the OB and DG. Once ablated,
progenitor proliferation was slow to recover even in the absence
of continuing GCV administration, and the rate of recovery dif-
fered among the neurogenic regions. Two weeks after the ces-
sation of GCV infusion, proliferation recovered in the SVZ but not
the SGZ, and no immature neurons were evident in the OB or
DG. After an extended recovery period of 6 weeks, both prolif-
eration and immature neurons were present bilaterally in the
SVZ/OB pathway, but the SGZ/DG pathway experienced only a
partial, unilateral recovery. These results suggest that the dy-
namics of progenitor proliferation differ significantly among the
SVZ and SGZ, although the nature of these differences remains
to be determined.
The nestin-tk mouse permits inducible ablation of
adult neurogenesis
We sought to produce a model system to facilitate the study
of adult neurogenesis and its role in neurophysiology and
behavior. Undesired systemic toxicity is a problem common
to the GFAP-tk mouse, which utilizes thymidine kinase ex-
pression to ablate GFAP-expressing neural progenitors (Bush
et al., 1998; Morshead et al., 2003; Garcia et al., 2004), and the
nestin-tk mouse. Here, we overcame this obstacle by infusing
GCV directly into the lateral ventricle, maximizing GCV admin-
istration to the brain while minimizing systemic exposure. This
approach allowed us to deliver GCV continuously for 28 days
without morbidity, facilitating a near-complete ablation of
adult neurogenesis. The need for implantation surgery is a
disadvantage of our model, and a small percentage of animals
had to be excluded due to surgical complications that in-
cluded infection and hemorrhage. However, in the vast ma-
jority we found no adverse effects of the surgery and chronic
infusion on activity and behavior, including the tail suspension
behavioral task used in this study.
Antimitotic agents (Doetsch et al., 1999; Shors et al., 2002),
x-irradiation (Mizumatsu et al., 2003), and transgenic expres-
sion of thymidine kinase under the GFAP promoter (Bush et
al., 1999; Garcia et al., 2004) have all been employed with
success to reduce or eliminate adult neurogenesis. These
approaches all act on nonneuronal cell populations as well,
and in particular alter the brain’s response to injury. Whereas
we focused on the ablation and recovery of immature neu-
rons, other studies utilizing the nestin 2nd intronic enhancer to
drive a reporter gene suggest that this regulatory element
drives only constitutive neurogenesis and does not play a role
in the injury response (Johansson et al., 2002). Thus, the
nestin-tk mouse may be a fruitful tool for the study of both the
normal physiological roles of neurogenesis and the function of
neurogenesis in neurologic disease and brain injury.
Reconstitution of neurogenesis after ablation in
the SVZ and SGZ
Progenitors in the SVZ and SGZ are normally maintained in
a quiescent state by signals within the stem cell niche (Ahn
and Joyner, 2005). Ablating the actively dividing fraction of the
Figure 7.
Six weeks after discontinuation of a 28-day ganciclovir (GCV) infusion, both proliferation and neurogenesis recover in the DG contralateral to
the site of GCV infusion. A,B: Mcm2-immunoreactive, proliferating cells are found only contralateral (C, lower left) to the side of GCV infusion
in the DG of a nestin-tk (tk) animal (B) as opposed to bilaterally in a wild-type (wt) control (A). C–E: Immature neurons immunolabeled for
doublecortin (DCx) are present contralateral (C, lower left) but not ipsilateral (I, lower left) to the side of GCV infusion in this tk mouse (D),
although more immature neurons are apparent in the wt control (C,E). GCL, granule cell layer; H, hilus; ML, molecular layer. Scale bar  50 m
in A (applies to A,B); 100 m in C (applies to C,D).
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stem cell population, however, leads normally quiescent pro-
genitors to enter the cell cycle (Doetsch et al., 1999; Seri et al.,
2001, 2004). When proliferating cells in the SVZ and SGZ are
eliminated with a brief antimitotic treatment, these newly ac-
tive progenitors rapidly repopulate the SVZ/OB and SGZ/DG
pathways (Doetsch et al., 1999; Seri et al., 2004). Here, how-
ever, we delivered GCV for 28 days, ablating successive frac-
tions of the progenitor population as they became active.
Nevertheless, the limited recovery of neurogenesis we ob-
served in both the SVZ and SGZ indicates that some progen-
itor cells do escape ablation, even after 28 days of GCV
treatment. The persistence of radial glia-like cells in the DG
after GCV treatment suggests that a subset of type 1 stem-like
cells may stop proliferating and thereby avoid GCV-induced
death. Also, the asymmetric recovery between ipsilateral and
contralateral DG likely resulted from the latter being exposed
to a lower GCV concentration, leading to greater recovery,
whereas the ipsilateral DG was exposed to higher GCV con-
centrations similar to those that would be expected in the SVZ
after ICV infusion. The greater recovery seen in the SVZ than
ipsilateral SGZ suggests that many SGZ progenitors more
readily enter the cell cycle and are thus more vulnerable to
elimination than their counterparts in the SVZ. Alternatively,
the remaining progenitors in the SVZ could proliferate at a
higher rate than in the SGZ, leading to faster SVZ recovery.
However, unlike mice treated with irradiation to eliminate the
cohort of actively dividing cells who then experience a surge
in compensatory proliferation in the SVZ (Tada et al., 1999),
nestin-tk mice seem to possess a limited regenerative ca-
pacity and repopulate the neurogenic zones more gradually. A
third possibility is that thymidine kinase is incompletely ex-
pressed in both progenitor populations, and differentially ex-
pressed in the SVZ and SGZ. The complete lack of neurogen-
esis in nestin-tk mice 2 weeks after the cessation of GCV
infusion, however, argues against a scenario in which a sub-
population of actively dividing progenitors escapes ablation
throughout the period of GCV administration.
Role of neurogenesis in antidepressant-like effects
One current theory proposes that hippocampal cell prolif-
eration and neurogenesis are the common therapeutic mech-
anisms of all known classes of antidepressant drugs. We
Figure 8.
A,B: Imipramine produced antidepressant-like effects in the tail suspension test in nonimplanted FVB mice (A) and in ganciclovir (GCV)-treated
wild-type (wt) and nestin-tk (tk) mice (B). In nonimplanted FVB mice (A), 28-day administration of imipramine (i.p.) produced dose-dependent
decreases in immobility with significant reductions observed at 10 and 30 mg/kg. Similarly, chronic administration of 10 and 30 mg/kg imipramine
significantly decreased immobility in the tail suspension test in GCV-treated wild-type and nestin-tk mice (B); however, there was no significant
difference between wild-type and nestin-tk mice. *, P < 0.05 compared with vehicle (0 mg/kg imipramine) and ***, P < 0.001 compared with vehicle
(0 mg/kg imipramine) as determined by one- or two-way ANOVA with Dunnett’s post hoc tests. C,D: Doublecortin immunostaining of representative
sections from GCV-treated wild-type (C) and nestin-tk mice (D) used in the depression studies. The transgenic mouse shows complete loss of
immature neurons (D), whereas the wild-type littermate maintains robust labeling (E). Scale bar  100 m in D (applies to C,D).
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therefore used our model system to test whether suppressing
neurogenesis alters the actions of antidepressants following
chronic administration. After daily imipramine administration
for 4 weeks, GCV-treated wild-type and nestin-tk mice dem-
onstrated similar antidepressant-like effects in the mouse tail
suspension test. Overall, these data suggest that neurogen-
esis is not required for the antidepressant actions of imipra-
mine as measured in the tail suspension model.
Our findings are consistent with some studies demonstrat-
ing that chronic antidepressant treatment did not increase
neurogenesis and that x-irradiation of the hippocampus did
not alter the antidepressant effects of fluoxetine (Meshi et al.,
2006; Holick et al., 2008; Huang et al., 2008; Surget et al.,
2008). However, other studies reported that proliferation was
reduced in animal models of depression, but that chronic
antidepressant treatment reversed this decrement (Kodama
et al., 2004; Bjornebekk et al., 2005; Chen et al., 2006; Jaako-
Movits et al., 2006; Lau et al., 2007; Perera et al., 2007; Qiu et
al., 2007; Marcussen et al., 2008; Warner-Schmidt et al., 2008).
Likewise, ablation of neurogenesis by x-irradiation of the hip-
pocampus eliminated the proliferation-promoting effects of
fluoxetine and imipramine and prevented their antidepressant-
like activity as measured in the novelty-suppressed feeding par-
adigm and chronic unpredictable stress model of depression
(Santarelli et al., 2003; Surget et al., 2008). Together, these data
suggest that the role of adult neurogenesis in depression-related
behaviors and antidepressant actions remains to be determined,
and that further investigation is needed to understand better the
biology of adult-born neurons.
In addition to its usefulness in studying the role of adult
neurogenesis in depression, the nestin-tk mouse offers utility
for investigating the functions of adult-born neurons in hip-
pocampal physiology, other behavioral paradigms, and neu-
rological disease models. Furthermore, because the loss of
adult-born neurons is not irreversible, this model system will
facilitate future investigations of how the neurogenic niche is
reconstituted after an insult, such as treatment of brain ma-
lignancies (Monje et al., 2007). Further studies using this
mouse will enhance our understanding, not only of the func-
tional role of adult neurogenesis in the brain, but also of the
basic dynamics underlying the birth, survival, and death of
adult-born neurons.
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